About AltaVoice
AltaVoice is a company based in San Mateo (United States) founded in 2004 was acquired by Invitae in January 2017. AltaVoice offers products and services including Genetic Testing Services and Genetic Counseling. AltaVoice operates in a competitive market with competitors including Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
Products & Services of AltaVoice
AltaVoice offers a comprehensive portfolio of products and services, including Genetic Testing Services and Genetic Counseling.
DNA analysis for health risk insights and personalized medicine.
Guidance on genetic test results and health decisions.
Investors in AltaVoice
AltaVoice has secured backing from 1 investor. Prominent investors backing the company include Invitae.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for AltaVoice
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of AltaVoice
2 dated milestones of AltaVoice across 13 years, from founding to its latest funding, stage changes and deals.
- Founded AltaVoice is founded.
- Exit Acquired by Invitae.
Competitors of AltaVoice
AltaVoice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inato.com | 2016 | Paris, France | $35.52M | – | AI-based patient recruitment platform | |
| gobalto.com | 2008 | San Francisco, United States | $38.25M | 66 | Cloud-based SaaS solutions for clinical trial startup are offered. | |
| novisci.com | 2016 | Durham, United States | – | – | Provider of an online scientific sourcing tool for researchers and professionals | |
| aclinicaltrials.com | 2017 | San Jose, United States | – | – | Provides an online database of clinical trial studies for researchers. | |
| clinata.com | 2012 | Dallas, United States | $100,000 | – | Online Clinical Research Marketplace | |
| dementiasplatform.uk | 2014 | Oxford, United Kingdom | – | – | Platform for dementia research, data access, and clinical trials collaboration. | |
| doctorpenguin.com | 2019 | United States | – | – | Provides an online platform with comprehensive health information for COVID-19. | |
| quosa.com | 2001 | Waltham, United States | – | – | Scientific Literature Management Software by Elsevier |
Detailed competitors of AltaVoice
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to AltaVoice
10 companies that operate in the same segment as AltaVoice (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AltaVoice
AltaVoice was founded in 2004.
AltaVoice is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
AltaVoice, (formerly PatientCrossroads) is a platform that collects, curates, coordinates and delivers data from patients, families and clinicians quickly (than traditional registries) and provides it to drug developers, advocacy groups and academic researchers and thereby helps in finding better treatments. For drug developers, it helps in saving cost and time for trial recruitment, patient education and long-term follow-up, while for academic researchers it serves as a data repository with patient insights which can be used in their research. The company claims to have developed programs for more than 400 diseases and also to have worked with 100 advocacy groups, NIH, PCORI (Patient-Centered Outcomes Research Institute), biotech and pharmaceutical companies.
AltaVoice offers Genetic Testing Services and Genetic Counseling.
AltaVoice has 1 investor. Key investors include Invitae.
Yes. AltaVoice was acquired by Invitae in January 2017.